search
Back to results

Rheumatology Clinical Registry (RCR)

Primary Purpose

Rheumatoid Arthritis

Status
Unknown status
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
American College of Rheumatology
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Rheumatoid Arthritis

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Clinical diagnosis of Rheumatoid Arthritis

Exclusion Criteria:

  • None

Sites / Locations

  • Registry SiteRecruiting

Outcomes

Primary Outcome Measures

Quality of the treatment of rheumatoid arthritis and other diseases

Secondary Outcome Measures

Submission to federal reporting programs

Full Information

First Posted
March 15, 2013
Last Updated
August 29, 2014
Sponsor
American College of Rheumatology
search

1. Study Identification

Unique Protocol Identification Number
NCT01813409
Brief Title
Rheumatology Clinical Registry
Acronym
RCR
Official Title
American College of Rheumatology Clinical Registry
Study Type
Observational

2. Study Status

Record Verification Date
August 2014
Overall Recruitment Status
Unknown status
Study Start Date
August 2009 (undefined)
Primary Completion Date
December 2015 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
American College of Rheumatology

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The ACR Rheumatology Clinical Registry (RCR) is a tool developed to assist members in practice improvement, local population management, and efficient, successful participation in national quality programs. RCR integrates evidence-based quality measures aimed at improving care and drug safety for patients with rheumatoid arthritis, osteoarthritis, osteoporosis, gout and juvenile idiopathic arthritis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rheumatoid Arthritis

7. Study Design

Enrollment
820 (Anticipated)
Target Follow-Up Duration
1 Year
Primary Outcome Measure Information:
Title
Quality of the treatment of rheumatoid arthritis and other diseases
Time Frame
Up to a year
Secondary Outcome Measure Information:
Title
Submission to federal reporting programs
Time Frame
Up to a year

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of Rheumatoid Arthritis Exclusion Criteria: None
Study Population Description
Rheumatology patients
Sampling Method
Non-Probability Sample
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Melissa Francisco
Phone
404-633-3777
Ext
102
Email
mfrancisco@rheumatology.org
First Name & Middle Initial & Last Name or Official Title & Degree
Rachel Myslinski
Phone
404-633-3777
Ext
824
Email
rmyslinski@rheumatology.org
Facility Information:
Facility Name
Registry Site
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30319
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Melissa Francisco
Phone
404-633-3777
Ext
102
Email
mfrancisco@rheumatology.org
First Name & Middle Initial & Last Name & Degree
Rachel Myslinski
Phone
404-633-3777
Ext
824
Email
rmyslinski@rheumatology.org

12. IPD Sharing Statement

Learn more about this trial

Rheumatology Clinical Registry

We'll reach out to this number within 24 hrs